SPS
TXG icon

Susquehanna Portfolio Strategies’s 10x Genomics TXG Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.33M Hold
298,230
– – 0.09% 268
2025
Q4 		$4.86M Hold
298,230
– – 0.08% 306
2025
Q3 		$3.49M Hold
298,230
– – 0.06% 376
2025
Q2 		$3.45M Buy
+298,230
New +$2.72M 0.08% 276

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna Portfolio Strategies's TXG Position: Q1 2026 in Review

Susquehanna Portfolio Strategies held its 10x Genomics (TXG) position steady in Q1 2026 at 298,230 shares worth $6.33M. The position accounts for 0.09% of the portfolio, ranked #268.

Susquehanna Portfolio Strategies first reported a position in TXG in Q2 2025 and has held it in 4 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Susquehanna Portfolio Strategies held 298,230 shares of 10x Genomics worth $6.33M as of Q1 2026.
  • Susquehanna Portfolio Strategies left its 10x Genomics share count unchanged in Q1 2026.
  • 10x Genomics made up 0.09% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #268 holding.
  • Susquehanna Portfolio Strategies first reported a position in 10x Genomics in Q2 2025 and has held it in 4 quarters since.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.